文献速递胃肠外科围术期管理与 ERAS

腹腔镜Nissen与Toupet胃底折叠术治疗III型和IV型食管裂孔疝的长期疗效比较

Long-term efficacy of laparoscopic Nissen versus Toupet fundoplication for the management of types III and IV hiatal hernias.
PubMed 文献 · Surg Endosc · 2018-11-26

本研究回顾性分析单中心7年间由同一术者完成的473例腹腔镜食管裂孔疝修补加补片加固术,其中179例III型或IV型食管裂孔疝符合纳入标准,62例行Toupet术,117例行Nissen术。通过 telefon 问卷调查(GERD-HRQOL)评估术后至少18个月的长期症状控制,结果显示两组患者报告的症状和满意度无显著差异。

要点

  • 对于III型和IV型食管裂孔疝,腹腔镜Nissen与Toupet胃底折叠术的长期患者报告症状控制相似。
  • 两组患者中位问卷应答均为0分(无症状),质子泵抑制剂使用率无显著差异(26% vs 31%, p=0.486)。
  • 患者对现状的满意度相似(Toupet 67% vs Nissen 72%, p=0.351)。

核心结论

  • 腹腔镜Nissen与Toupet胃底折叠术治疗III型和IV型食管裂孔疝的长期患者报告症状和满意度无显著差异,提示两种术式均可提供相似的长期症状控制。

研究设计与样本

  • 单中心回顾性队列研究,纳入7年间由同一术者完成的腹腔镜食管裂孔疝修补加补片加固术患者,排除I型、II型、复发疝及合并其他手术者,最终纳入179例III型或IV型食管裂孔疝患者(Toupet组62例,Nissen组117例)。
  • 通过电话方式在术后至少18个月时进行GERD-健康相关生活质量(GERD-HRQOL)问卷调查,共77例(43%)完成问卷(Nissen组50例,Toupet组27例)。

主要发现

  • 患者平均年龄64岁,女性占63%,两组人口学特征、合并症及术中因素相似。
  • 问卷完成中位时间:Nissen组54个月,Toupet组25个月;两组所有条目的中位应答均为0(无症状),组间无显著差异。
  • Nissen组26%报告当前使用质子泵抑制剂,Toupet组为31%(p=0.486)。
  • 患者对当前状况的满意度:Toupet组67%,Nissen组72%(p=0.351)。

临床怎么用

  • 对于III型和IV型食管裂孔疝患者,选择腹腔镜Nissen或Toupet胃底折叠术均可考虑,长期症状控制效果相似。

局限性

  • 回顾性单中心研究,样本量有限,问卷应答率仅43%,可能存在选择偏倚。
  • 两组问卷完成时间的中位随访时间不一致(Nissen组54个月 vs Toupet组25个月),可能影响长期结果的比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic hiatal hernia repair via Toupet or Nissen fundoplication remains the most commonly performed procedures for management of large hiatal hernia. Few studies have compared the procedures' long-term effectiveness. This study sought to characterize the efficacy of laparoscopic Toupet versus Nissen fundoplication for types III and IV hiatal hernia. METHODS: With IRB approval, a review of all laparoscopic hiatal hernia repairs with mesh reinforcement performed over 7 years at a single center by one surgeon was conducted. Hiatal hernias were classified as type III or IV using operative reports and preoperative imaging. Patients with type I, II, or recurrent hiatal hernia and patients receiving concomitant procedures were excluded. The GERD-Health Related Quality of Life Survey was administered by telephone no earlier than 18 months postoperatively. RESULTS: A total of 473 patients underwent laparoscopic fundoplication; 179 having type III or IV hiatal hernia met inclusion criteria; 62 underwent Toupet, 117 underwent Nissen fundoplication. Average patient age was 64 years; 63% of patients were female. Cohorts were similar in demographics, comorbidities, and intraoperative factors. Survey was completed by 77 patients (43%): 50 having Nissen and 27 Toupet. Median time of survey completion after surgery was 54 months (Nissen) and 25 months (Toupet). Median survey responses across all items for both groups were 0 (no symptoms) with no significant variation between groups. Of patients that had Nissen, 26% reported current proton-pump inhibitor use versus 31% of Toupet patients (p = 0.486). Patient-reported satisfaction with current condition was similar between groups (67% Toupet, 72% Nissen, p = 0.351). CONCLUSIONS: Patient-reported symptoms and satisfaction did not vary for patients receiving laparoscopic Nissen versus Toupet fundoplication, which may indicate that patients with large type III and IV hiatal hernia undergoing either procedure have similar long-term postoperative symptom control.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Huerta CT, Plymale M, Barrett P, et al. Long-term efficacy of laparoscopic Nissen versus Toupet fundoplication for the management of types III and IV hiatal hernias. Surg Endosc. 2018. PMID: 30478698. doi:10.1007/s00464-018-6589-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。